Search Results

There are 51526 results for: content related to: Laboratory assessment of the anticoagulant effects of the next generation of oral anticoagulants

  1. Rivaroxaban: Practical Considerations for Ensuring Safety and Efficacy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 33, Issue 11, November 2013, Pages: 1223–1245, Maureen A. Smythe, John Fanikos, Michael P. Gulseth, Ann K. Wittkowsky, Sarah A. Spinler, William E. Dager and Edith A. Nutescu

    Version of Record online : 26 MAY 2013, DOI: 10.1002/phar.1289

  2. You have free access to this content
    Rivaroxaban for the treatment and prevention of thromboembolic disease

    Journal of Pharmacy and Pharmacology

    Volume 67, Issue 8, August 2015, Pages: 1119–1132, Sotiris Antoniou

    Version of Record online : 9 JUN 2015, DOI: 10.1111/jphp.12387

  3. Laboratory measurement of the direct oral anticoagulants

    British Journal of Haematology

    Volume 172, Issue 3, February 2016, Pages: 315–336, Brian J. Dale, Noel C. Chan and John W. Eikelboom

    Version of Record online : 22 OCT 2015, DOI: 10.1111/bjh.13810

  4. Current challenges and future prospects in oral anticoagulant therapy

    British Journal of Haematology

    Julia Czuprynska, Jignesh P. Patel and Roopen Arya

    Version of Record online : 2 JUN 2017, DOI: 10.1111/bjh.14714

  5. You have free access to this content
    Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 2, April 2014, Pages: 118–135, J. W. Cheng and G. Barillari

    Version of Record online : 3 JAN 2014, DOI: 10.1111/jcpt.12122

  6. The discovery and development of rivaroxaban

    Annals of the New York Academy of Sciences

    Volume 1222, Issue 1, March 2011, Pages: 64–75, Frank Misselwitz, Scott D. Berkowitz and Elisabeth Perzborn

    Version of Record online : 22 MAR 2011, DOI: 10.1111/j.1749-6632.2011.05971.x

  7. You have free access to this content
    The role of the laboratory in treatment with new oral anticoagulants

    Journal of Thrombosis and Haemostasis

    Volume 11, Issue s1, June 2013, Pages: 122–128, T. Baglin

    Version of Record online : 30 JUN 2013, DOI: 10.1111/jth.12227

  8. You have free access to this content
    Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism

    Intervention Review

    The Cochrane Library

    Lindsay Robertson, Patrick Kesteven and James E McCaslin

    Published Online : 4 DEC 2015, DOI: 10.1002/14651858.CD010957.pub2

  9. Rivaroxaban: a novel oral anticoagulant for the prevention and treatment of several thrombosis-mediated conditions

    Annals of the New York Academy of Sciences

    Volume 1291, Issue 1, July 2013, Pages: 42–55, Troy C. Sarich, Gary Peters, Scott D. Berkowitz, Frank Misselwitz, Christopher C. Nessel, Paul Burton, Nancy Cook-Bruns, Anthonie W.A. Lensing, Lloyd Haskell, Elisabeth Perzborn, Dagmar Kubitza, Kenneth T. Moore, Sanjay Jalota, Juergen Weber, Guohua Pan, Xiang Sun, Torsten Westermeier, Andrea Nadel, Leonard Oppenheimer and Peter M. DiBattiste

    Version of Record online : 23 MAY 2013, DOI: 10.1111/nyas.12136

  10. You have free access to this content
    Implications of new anticoagulants in primary practice

    International Journal of Clinical Practice

    Volume 67, Issue 2, February 2013, Pages: 139–156, A. Perez, L. H. Eraso and G. J. Merli

    Version of Record online : 11 JAN 2013, DOI: 10.1111/ijcp.12023

    Corrected by:

    Erratum: Erratum

    Vol. 67, Issue 8, 816, Version of Record online: 22 JUL 2013

  11. You have free access to this content
    Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis

    Intervention Review

    The Cochrane Library

    Lindsay Robertson, Patrick Kesteven and James E McCaslin

    Published Online : 30 JUN 2015, DOI: 10.1002/14651858.CD010956.pub2

  12. You have full text access to this OnlineOpen article
    Rivaroxaban – an oral, direct Factor Xa inhibitor – lessons from a broad clinical study programme

    European Journal of Haematology

    Volume 82, Issue 5, May 2009, Pages: 339–349, Sylvia Haas

    Version of Record online : 28 JAN 2009, DOI: 10.1111/j.1600-0609.2009.01230.x

  13. Role of Orally Available Antagonists of Factor Xa in the Treatment and Prevention of Thromboembolic Disease: Focus on Rivaroxaban

    The Journal of Clinical Pharmacology

    Volume 50, Issue 9, September 2010, Pages: 986–1000, Jason Morell, Bridgette Sullivan, Marina Khalabuda and Brian F. McBride

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009355814

  14. Pharmacology and mechanisms of action of new oral anticoagulants

    Fundamental & Clinical Pharmacology

    Volume 29, Issue 1, February 2015, Pages: 10–20, Joe-Elie Salem, Pierre Sabouret, Christian Funck-Brentano and Jean-Sebastien Hulot

    Version of Record online : 25 SEP 2014, DOI: 10.1111/fcp.12091

  15. You have full text access to this OnlineOpen article
    Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with non-valvular atrial fibrillation: Results from ROCKET AF

    The Journal of Clinical Pharmacology

    Volume 54, Issue 8, August 2014, Pages: 917–927, I.G. Girgis, M.R. Patel, G.R. Peters, K.T. Moore, K.W. Mahaffey, C.C. Nessel, J.L. Halperin, R.M. Califf, K.A.A. Fox and R.C. Becker

    Version of Record online : 26 MAR 2014, DOI: 10.1002/jcph.288

  16. Rivaroxaban: A Novel, Oral, Direct Factor Xa Inhibitor

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 2, February 2009, Pages: 167–181, Paris J. Abrams and Christopher R. Emerson

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.2.167

  17. You have free access to this content
    Pharmacodynamic and pharmacokinetic basics of rivaroxaban

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 1, February 2012, Pages: 27–32, Reinhold Kreutz

    Version of Record online : 16 AUG 2011, DOI: 10.1111/j.1472-8206.2011.00981.x

  18. You have free access to this content
    Novel anticoagulants and laboratory testing

    International Journal of Laboratory Hematology

    Volume 35, Issue 3, June 2013, Pages: 262–268, C. Eby

    Version of Record online : 17 APR 2013, DOI: 10.1111/ijlh.12065

  19. You have free access to this content
    Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair

    Intervention Review

    The Cochrane Library

    Rachel Forster and Marlene Stewart

    Published Online : 30 MAR 2016, DOI: 10.1002/14651858.CD004179.pub2

  20. You have free access to this content
    Measurement of non-Coumarin anticoagulants and their effects on tests of Haemostasis: Guidance from the British Committee for Standards in Haematology

    British Journal of Haematology

    Volume 166, Issue 6, September 2014, Pages: 830–841, Steve Kitchen, Elaine Gray, Ian Mackie, Trevor Baglin, Mike Makris and on behalf of the BCSH committee

    Version of Record online : 14 JUN 2014, DOI: 10.1111/bjh.12975